The University of Alabama Health Services Foundation General Endowment Fund awarded grants to aid research across UAB.
Newly named condition, “isolated diastolic hypotension,” can be difficult to treat while increasing risk of death.
New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off dialysis.
With the acquisition, UAB takes a significant step toward making sophisticated cell therapy a part of patient care.
By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.